TableEdit
OMP ST:1026 ! Escherichia coli K-12 JW3595
You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki
See Help for Help on this wiki. See the documentation for how to use the table editor
A conflict has been detected between the version of this table in the wiki and the copy you are editing.Rows in conflict with the working copy:
Annotation ID | Qualifier | OMP ID | OMP term name | Relative phenotype information | Experimental condition | ECO ID | ECO term name | Reference | Annotation Extension | Notes | |
---|---|---|---|---|---|---|---|---|---|---|---|
public |
OMP_AN:33776 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:27518 Genotype differences: +rfaF732(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:2955) Azithromycin |
| |
public |
OMP_AN:33777 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27571 Genotype differences: +rfaF732(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:3259) CCCP (Carbonyl cyanide 3-chlorophenylhydrazone) |
| |
public |
OMP_AN:33778 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:27535 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:31380) Cefsulodin sodium salt hydrate |
| |
public |
OMP_AN:33779 |
OMP:0007250 |
increased resistance to a chemical |
Relative to: OMP_AN:27511 Genotype differences: +rfaF732(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:28918) (-)-Epinephrine |
| |
public |
OMP_AN:33780 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:27520 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:42355) Erythromycin |
| |
public |
OMP_AN:33781 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27515 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CID:126963539) Fusidic acid sodium salt |
| |
public |
OMP_AN:33782 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:27537 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:51208) Mecillinam |
| |
public |
OMP_AN:33783 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27513 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8055) Phenazine methosulfate (PMS) |
| |
public |
OMP_AN:33784 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27573 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8431) Procaine hydrochloride |
| |
public |
OMP_AN:33785 |
OMP:0007878 |
increased resistance to an antimicrobial agent |
Relative to: OMP_AN:27553 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8642) Puromycin dihydrochloride |
| |
public |
OMP_AN:33786 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:27543 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:9287) Streptonigrin |
| |
public |
OMP_AN:33787 |
OMP:0006058 |
increased resistance to aminoglycoside |
Relative to: OMP_AN:27529 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:28864) Tobramycin |
| |
public |
OMP_AN:33788 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27588 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:164200) Triclosan/Irgasan |
| |
public |
OMP_AN:33789 |
OMP:0007250 |
increased resistance to a chemical |
Relative to: OMP_AN:27568 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:53188) (±)-Verapamil hydrochloride |
| |
public |
OMP_AN:33790 |
OMP:0006041 |
increased resistance to quinolone |
Relative to: OMP_AN:27539 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:59936) Ciprofloxacin hydrochloride hydrate |
| |
public |
OMP_AN:33791 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:27541 Genotype differences: +rfaF732(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CID:3864541) Nalidixic acid sodium salt |
| |
public |
OMP_AN:33792 |
OMP:0007010 |
decreased population growth at alkaline pH |
Relative to: OMP_AN:27623 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: pH:8.0? |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
| ||
public |
OMP_AN:33793 |
OMP:0007008 |
decreased population growth at acidic pH |
Relative to: OMP_AN:27622 Genotype differences: +rfaF732(del) Condition differences: pH:4.0? |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
| ||
public |
OMP_AN:33794 |
OMP:0007009 |
increased population growth at acidic pH |
Relative to: OMP_AN:27622 Genotype differences: +rfaF732(del) Condition differences: pH:6.0? |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
| ||
public |
OMP_AN:33795 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27591 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:45924 + CHEBI:9331) Trimethoprim (CHEBI:45924) + Sulfamethizole (CHEBI:9331) |
|
The rows shown above are different from the working copy.
This includes rows that have been edited and rows that are missing in the copy you are editing.
Copy desired rows to the working version until you have what you need, then continue editing.
Working copy:
The highlighted rows are different from the copy of the table from the wiki. This includes rows that have been edited and rows that you added. You can delete rows from the working copy in this view before continuing.Annotation ID | Qualifier | OMP ID | OMP term name | Relative phenotype information | Experimental condition | ECO ID | ECO term name | Reference | Annotation Extension | Notes | |
---|---|---|---|---|---|---|---|---|---|---|---|
public |
OMP_AN:937 |
OMP:0007092 |
decreased cell motility by swarming |
Relative to: OMP_AN:881 Genotype differences: +DE(araD-araB)567 +DE(rhaD-rhaB)568 +hsdR514 +lacZ4787(del)( +rfaF732(del) -IN(rrnD-rrnE)1 Condition differences: no differences |
|
ECO:0005803 |
motility assay evidence |
PMID:17122336 |
|||
public |
OMP_AN:1141 |
OMP:0005324 |
altered cell motility by swimming |
Relative to: OMP_AN:882 Genotype differences: +DE(araD-araB)567 +DE(rhaD-rhaB)568 +hsdR514 +lacZ4787(del)( +rfaF732(del) -IN(rrnD-rrnE)1 Condition differences: no differences |
|
ECO:0005803 |
motility assay evidence |
PMID:17122336 |
|||
public |
OMP_AN:33776 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:27518 Genotype differences: +rfaF732(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:2955) Azithromycin |
| |
public |
OMP_AN:33777 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27571 Genotype differences: +rfaF732(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:3259) CCCP (Carbonyl cyanide 3-chlorophenylhydrazone) |
| |
public |
OMP_AN:33778 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:27535 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:31380) Cefsulodin sodium salt hydrate |
| |
public |
OMP_AN:33779 |
OMP:0007250 |
increased resistance to a chemical |
Relative to: OMP_AN:27511 Genotype differences: +rfaF732(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:28918) (-)-Epinephrine |
| |
public |
OMP_AN:33780 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:27520 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:42355) Erythromycin |
| |
public |
OMP_AN:33781 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27515 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CID:126963539) Fusidic acid sodium salt |
| |
public |
OMP_AN:33782 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:27537 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:51208) Mecillinam |
| |
public |
OMP_AN:33783 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27513 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8055) Phenazine methosulfate (PMS) |
| |
public |
OMP_AN:33784 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27573 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8431) Procaine hydrochloride |
| |
public |
OMP_AN:33785 |
OMP:0007878 |
increased resistance to an antimicrobial agent |
Relative to: OMP_AN:27553 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8642) Puromycin dihydrochloride |
| |
public |
OMP_AN:33786 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:27543 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:9287) Streptonigrin |
| |
public |
OMP_AN:33787 |
OMP:0006058 |
increased resistance to aminoglycoside |
Relative to: OMP_AN:27529 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:28864) Tobramycin |
| |
public |
OMP_AN:33788 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27588 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:164200) Triclosan/Irgasan |
| |
public |
OMP_AN:33789 |
OMP:0007250 |
increased resistance to a chemical |
Relative to: OMP_AN:27568 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:53188) (±)-Verapamil hydrochloride |
| |
public |
OMP_AN:33790 |
OMP:0006041 |
increased resistance to quinolone |
Relative to: OMP_AN:27539 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:59936) Ciprofloxacin hydrochloride hydrate |
| |
public |
OMP_AN:33791 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:27541 Genotype differences: +rfaF732(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CID:3864541) Nalidixic acid sodium salt |
| |
public |
OMP_AN:33792 |
OMP:0007010 |
decreased population growth at alkaline pH |
Relative to: OMP_AN:27623 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: pH:8.0? |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
| ||
public |
OMP_AN:33793 |
OMP:0007008 |
decreased population growth at acidic pH |
Relative to: OMP_AN:27622 Genotype differences: +rfaF732(del) Condition differences: pH:4.0? |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
| ||
public |
OMP_AN:33794 |
OMP:0007009 |
increased population growth at acidic pH |
Relative to: OMP_AN:27622 Genotype differences: +rfaF732(del) Condition differences: pH:6.0? |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
| ||
public |
OMP_AN:33795 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27591 Genotype differences: +lacZ4787(del)( +rfaF732(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:45924 + CHEBI:9331) Trimethoprim (CHEBI:45924) + Sulfamethizole (CHEBI:9331) |
|
Cancel |